Cyclacel Pharmaceuticals is a biotechnology business based in the US. Cyclacel Pharmaceuticals shares (CYCC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.32 – an increase of 7.74% over the previous week.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – CYCC.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Cyclacel Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Cyclacel Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cyclacel Pharmaceuticals price performance over time
Historical closes compared with the close of $0.32 from 2025-03-21
1 week (2025-03-14)
7.74%
1 month (2025-02-21)
-5.88%
3 months (2024-12-23)
-1.66%
6 months (2024-09-23)
-67.68%
1 year (2024-03-22)
-85.37%
2 years (2023-03-22)
-96.20%
3 years (2022-03-22)
49.2
5 years (2020-03-20)
98.97
Cyclacel Pharmaceuticals financials
Revenue TTM
$74,000
Gross profit TTM
$74,000
Return on assets TTM
-108.63%
Return on equity TTM
-807.39%
Profit margin
0%
Book value
$-0.45
Market Capitalization
$61.1 million
TTM: trailing 12 months
Cyclacel Pharmaceuticals share dividends
We're not expecting Cyclacel Pharmaceuticals to pay a dividend over the next 12 months.
Have Cyclacel Pharmaceuticals's shares ever split?
Cyclacel Pharmaceuticals's shares were
split on a 1:15 basis on 17 December 2023
. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cyclacel Pharmaceuticals shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Cyclacel Pharmaceuticals shares which in turn could have impacted Cyclacel Pharmaceuticals's share price.
Cyclacel Pharmaceuticals share price volatility
Over the last 12 months, Cyclacel Pharmaceuticals's shares have ranged in value from as little as $0.2939 up to $4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cyclacel Pharmaceuticals's is 0.285. This would suggest that Cyclacel Pharmaceuticals's shares are less volatile than average (for this exchange).
Cyclacel Pharmaceuticals overview
Cyclacel Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey. .
Frequently asked questions
null What percentage of Cyclacel Pharmaceuticals is owned by insiders or institutions? Currently 94.587% of Cyclacel Pharmaceuticals shares are held by insiders and 0.354% by institutions.When does the fiscal year end for Cyclacel Pharmaceuticals? Cyclacel Pharmaceuticals's fiscal year ends in December.Where is Cyclacel Pharmaceuticals based? Cyclacel Pharmaceuticals's address is: 200 Connell Drive, Berkeley Heights, NJ, United States, 07922What is Cyclacel Pharmaceuticals's ISIN number? Cyclacel Pharmaceuticals's international securities identification number is: US23254L6039What is Cyclacel Pharmaceuticals's CUSIP number? Cyclacel Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 23254L603
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
